Titan Pharmaceuticals, Inc. (TTNP) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 | Q4'20 | Q3'20 |
|---|
| Total Current Assets | 3.05M | 2.16M | 2.92M | 3.6M | 4.35M | 6.61M | 8.02M | 9.9M | 498K | 1.78M | 3.6M | 5.75M | 7.71M | 9.63M | 7.23M | 8.85M | 10.63M | 13.19M | 7.33M | 6.65M |
| Cash & Short-Term Investments | 2.8M | 1.95M | 2.83M | 3.4M | 4.09M | 6.16M | 6.76M | 8.1M | 105K | 1.14M | 2.94M | 4.45M | 6.42M | 8.14M | 6.04M | 7.42M | 9.68M | 11.63M | 5.41M | 4.07M |
| Cash Only | 2.8M | 1.95M | 2.83M | 3.4M | 4.09M | 6.16M | 6.76M | 8.1M | 105K | 1.14M | 2.94M | 4.45M | 6.42M | 8.14M | 6.04M | 7.42M | 9.68M | 11.63M | 5.41M | 4.07M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 143K | 81K | 62K | 52K | 38K | 134K | 1.05M | 1.53M | 9K | 8K | 36K | 49K | 101K | 218K | 112K | 265K | 103K | 398K | 884K | 423K |
| Days Sales Outstanding | - | - | 2.26K | - | - | - | 4.71K | 139.25K | 3.29K | 29.8 | 257.65 | 4.47K | 245.77 | 414.43 | 302.81 | 366.38 | 84.48 | 213.01 | 305.26 | 137.85 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 106K | 106K | 460K | 469K | 293K | 293K | 129K | 129K | 218K | 328K | 1.07M |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | 899.77 | - | 180.15 | 3.36K | 2.06K | 2.02K | 39.47 | 529.04 | 723.36 | 58.54 | 573.42 |
| Other Current Assets | 105K | 130K | 30K | 151K | 220K | 318K | 212K | 277K | 384K | 535K | 524K | 276K | 179K | 235K | 307K | 187K | 70K | 128K | 181K | 0 |
| Total Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 35K | 68K | 100K | 314K | 383K | 455K | 529K | 606K | 685K | 765K | 792K | 877K | 635K | 759K | 1.37M |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 35K | 68K | 100K | 133K | 335K | 407K | 481K | 558K | 637K | 717K | 792K | 877K | 635K | 759K | 1.37M |
| Fixed Asset Turnover | - | - | - | - | - | - | 1.19x | 0.04x | 0.01x | 0.29x | 0.13x | 0.01x | 0.27x | 0.30x | 0.19x | 0.33x | 0.51x | 1.07x | 1.39x | 0.82x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 181K | 48K | 48K | 48K | 48K | 48K | 48K | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 3.05M | 2.16M | 2.92M | 3.6M | 4.35M | 6.65M | 8.09M | 10M | 812K | 2.17M | 4.06M | 6.28M | 8.32M | 10.32M | 7.99M | 9.64M | 11.51M | 13.82M | 8.09M | 8.02M |
| Asset Turnover | - | - | 0.00x | - | - | - | 0.01x | 0.00x | 0.00x | 0.05x | 0.01x | 0.00x | 0.02x | 0.02x | 0.02x | 0.03x | 0.04x | 0.05x | 0.13x | 0.14x |
| Asset Growth % | -29.86% | -67.56% | -63.85% | -63.98% | 435.71% | 206.55% | 99.26% | 59.32% | -90.24% | -78.99% | -49.24% | -34.88% | -27.7% | -25.36% | -1.15% | 20.19% | 17.88% | 4.24% | -15.07% | 51.17% |
| Total Current Liabilities | 263K | 279K | 483K | 371K | 356K | 559K | 1.44M | 1.87M | 1.85M | 2.45M | 2.63M | 2.63M | 2.52M | 2.28M | 2.67M | 1.93M | 2.52M | 3.76M | 4.22M | 5.88M |
| Accounts Payable | 219K | 194K | 202K | 371K | 356K | 371K | 348K | 407K | 597K | 567K | 695K | 812K | 443K | 468K | 795K | 386K | 439K | 768K | 1.25M | 1.75M |
| Days Payables Outstanding | - | - | - | - | - | - | 42.34K | 5.5K | 493 | 4.81K | - | 318 | 3.17K | 3.29K | 5.47K | 118.1 | 1.8K | 2.55K | 223.64 | 935.21 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 500K | 500K | 0 | 0 | 0 | 120K | 117K | 114K | 112K | 109K | 108K | 648K | 327K | 2.3M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 12K | 12K | 16K | 98K | 196K | 261K | 165K | 211K | 295K | 317K | 342K | 447K | 533K | 0 |
| Other Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 60K | 426K | 187K | 129K | 750K | 1.01M | 1.01M | 1.03M | 1M | 1.52M | 1.82M | 1.96M | -129K |
| Current Ratio | 11.60x | 7.73x | 6.05x | 9.71x | 12.22x | 11.83x | 5.55x | 5.30x | 0.27x | 0.73x | 1.37x | 2.19x | 3.06x | 4.23x | 2.71x | 4.59x | 4.22x | 3.51x | 1.74x | 1.13x |
| Quick Ratio | 11.60x | 7.73x | 6.05x | 9.71x | 12.22x | 11.83x | 5.55x | 5.30x | 0.27x | 0.69x | 1.33x | 2.01x | 2.87x | 4.10x | 2.60x | 4.53x | 4.17x | 3.45x | 1.66x | 0.95x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | -3.88K | - | 4.33K | 431.85 | -813.94 | -3.15K | 287.75 | -1.19K | -1.61K | 140.16 | -223.94 |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33K | 65K | 96K | 128K | 158K | 187K | 216K | 244K | 88K | 332K | 3.04M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 88K | 332K | 3.04M |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33K | 65K | 96K | 128K | 158K | 187K | 216K | 244K | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 263K | 279K | 483K | 371K | 356K | 559K | 1.44M | 1.87M | 1.85M | 2.48M | 2.69M | 2.73M | 2.65M | 2.44M | 2.86M | 2.14M | 2.76M | 3.84M | 4.55M | 8.91M |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 33K | 565K | 597K | 128K | 158K | 187K | 216K | 245K | 272K | 299K | 325K | 352K | 736K | 809K | 5.34M |
| Net Debt | -2.8M | -1.95M | -2.83M | -3.4M | -4.09M | -6.13M | -6.2M | -7.5M | 23K | -978K | -2.75M | -4.23M | -6.17M | -7.87M | -5.74M | -7.09M | -9.33M | -10.89M | -4.6M | 1.27M |
| Debt / Equity | - | - | - | - | - | 0.01x | 0.09x | 0.07x | - | - | 0.14x | 0.06x | 0.04x | 0.03x | 0.06x | 0.04x | 0.04x | 0.07x | 0.23x | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.13x | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.77x | - |
| Interest Coverage | - | - | - | - | - | - | -58.52x | -187.36x | - | - | - | - | -488.40x | -2539.00x | -829.67x | - | - | -2632.00x | 116.31x | -19.00x |
| Total Equity | 2.79M | 1.88M | 2.44M | 3.23M | 3.99M | 6.09M | 6.64M | 8.13M | -1.03M | -312K | 1.36M | 3.55M | 5.67M | 7.88M | 5.14M | 7.5M | 8.75M | 9.98M | 3.53M | -897K |
| Equity Growth % | -30.2% | -69.16% | -63.26% | -60.27% | 486.27% | 2050.96% | 387.31% | 129.1% | -118.25% | -103.96% | -73.47% | -52.64% | -35.21% | -21.02% | 45.47% | 935.67% | 460.71% | 89.16% | 146.48% | 66.28% |
| Book Value per Share | 2.62 | 2.05 | 2.71 | 3.54 | 4.37 | 7.14 | 8.50 | 10.83 | -1.38 | -0.42 | 1.92 | 4.85 | 2.84 | 3.95 | 2.57 | 3.75 | 4.38 | 5.00 | 1.77 | -0.27 |
| Total Shareholders' Equity | 2.79M | 1.88M | 2.44M | 3.23M | 3.99M | 6.09M | 6.64M | 8.13M | -1.03M | -312K | 1.36M | 3.55M | 5.67M | 7.88M | 5.14M | 7.5M | 8.75M | 9.98M | 3.53M | -897K |
| Common Stock | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 15K | 15K | 15K | 1K | 15K | 15K | 12K | 10K | 10K | 10K | 10K | 7K | 117K |
| Retained Earnings | -397.79M | -397.1M | -396.54M | -395.75M | -394.98M | -392.89M | -391.83M | -389.86M | -389.52M | -387.94M | -386.26M | -383.69M | -381.06M | -378.6M | -376.06M | -373.51M | -371.6M | -369.92M | -367.28M | -364.19M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |